
Robert F. Kennedy Jr., a prominent critic of the food and pharmaceutical industries, discussed his views regarding GLP-1 weight loss drugs in a televised broadcast.
Kennedy, who was nominated by President-elect Donald Trump to lead the Department of Health and Human Services (HHS), said that lifestyle changes — specifically healthy eating and avoiding obesity — should be the primary approach to weight management.